Are Tungsten Corp PLC And Monitise Plc On The Road To Recovery?

Are Tungsten Corp PLC (LON: TUNG) and Monitise Plc (LON: MONI) about to rally?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

2015 has turned out to be a year that Tungsten (LSE: TUNG) and Monitise’s (LSE: MONI) investors would rather forget. Indeed, both companies have made some mistakes throughout the year, and it has become apparent that the market no longer trusts Tungsten and Monitise. Year to date, Tungsten’s shares have lost 75% while Monitise is down 76%. 

However, over the past month there have been some signs that the market is starting to trust these two companies once again. Tungsten and Monitise could be on the road to recovery. 

Regaining trust 

Invoicing, analytics and financing company Tungsten has continually disappointed since its initial public offering in 2013.

Over the past 12 months, the company’s shares have lost 82% of their value as the company has consistently failed to meet the growth targets set by management. And as the company’s cash balance has dwindled, earlier this year Tungsten was forced to conduct a placing to raise £17.5m. 

Nearly six months on from the placing and Tungsten hasn’t released much in the way of news to suggest that trading has improved. Nevertheless, the company’s preliminary results for the year ended 30 April 2015 showed that its key performance indicators were all moving in the right direction. The number of buyers using the company’s electronic invoicing network jumped by 39.5% and the number of suppliers using the system increased by 7.7% to 181,000. The total value of transactions over the network ticked higher by 10% to £121bn.

Moreover, since the end of July some of Tungsten’s directors have taken the plunge to add to their holdings of the company’s shares. So, things could be looking up for the company. Only time will tell. 

Disappointing 

Monitise hasn’t issued any news releases during the past few months, but that doesn’t mean there’s nothing going on behind the scenes. Under the leadership of new CEO Elizabeth Buse, the company has been working to reduce its cost base over the past year, which should improve margins.

Further, according to the company’s latest press release, Monitise is still on track to meet its goal of achieving profitability on an earnings before interest, tax, depreciation and amortization basis next year. Also, management believes that the group has enough cash on hand to finance the company through to break-even and beyond. 

Still, Monitise has a lot to prove before the company can regain the trust of shareholders and head higher. However, investors don’t have long to wait for an update on the company’s progress. Monitise is scheduled to release its full-year 2015 results this Wednesday. 

Unfortunately, in my opinion, Wednesday’s results will be Monitise’s last chance to prove that it really is on the road to recovery. If the company warns on profits once again, reveals yet another surprise fundraising or lowers its outlook for growth, it could be time for investors to give up on the company. On the other hand, if Monitise surprises to the upside, the company will be on the road to recovery. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK owns shares of Monitise. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s why Aston Martin’s one of the best-performing UK stocks today!

Several UK stocks pushed upwards on 24 July, and this iconic, British car manufacturer was among the best performers. Why…

Read more »

Investing Articles

Down 85%, but I’m backing this FTSE 250 stock to fly like the Rolls-Royce share price

The Rolls-Royce share price has flown to the stars and Harvey Jones thinks it's too late to buy. So he's…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Is now the right time for me to buy revived FTSE national institution Marks and Spencer?

Marks and Spencer was once a revered FTSE 100 firm, but poor decisions led to its demotion in 2019. Now…

Read more »

Market Movers

Up 11% today, can this FTSE 250 stock finally get motoring?

Jon Smith explains why the Aston Martin share price has jumped this morning, but urges caution after he picks apart…

Read more »

Investing Articles

With £456m of net cash, FTSE 100 stock easyJet’s ready for take-off

Our writer's been positive on this FTSE 100 for some time, but these Q3 results and its growing cash pile…

Read more »

A senior woman sits up on the exam table at a doctors appointment. She is dressed casually in a blue sweater and has a smile on her face as she glances at the doctor. Her female doctor is wearing a white lab coat and seated in front of her as she takes notes on a tablet.
Investing Articles

Primary Health Properties: a FTSE 250 REIT with a 6% yield, a growing dividend, and a positive outlook

After its latest results show rental income growth, Stephen Wright's looking to buy a FTSE 250 REIT set to benefit…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

How much passive income could I make for every £1,000 invested in Aviva shares?

Even a relatively small investment in Aviva shares could generate much greater passive income, particularly if the dividends are reinvested…

Read more »

Close-up of British bank notes
Investing Articles

I’m considering 100 shares in this FTSE 250 gem to aim for £300 a month in dividends

Mark Hartley outlines why a lesser-known banking stock from the FTSE 250's worth considering for an income portfolio in 2024.

Read more »